172 related articles for article (PubMed ID: 38129531)
1. Tg1.4HBV-s-rec mice, a crossbred hepatitis B virus-transgenic model, develop mild hepatitis.
Schefczyk S; Luo X; Liang Y; Hasenberg M; Walkenfort B; Trippler M; Schuhenn J; Sutter K; Lu M; Wedemeyer H; Schmidt HH; Broering R
Sci Rep; 2023 Dec; 13(1):22829. PubMed ID: 38129531
[TBL] [Abstract][Full Text] [Related]
2. Poly(I:C) Induces Distinct Liver Cell Type-Specific Responses in Hepatitis B Virus-Transgenic Mice In Vitro, but Fails to Induce These Signals In Vivo.
Schefczyk S; Luo X; Liang Y; Trippler M; Lu M; Wedemeyer H; Schmidt HH; Broering R
Viruses; 2023 May; 15(5):. PubMed ID: 37243287
[TBL] [Abstract][Full Text] [Related]
3. Replication and gene expression of mutant hepatitis B virus in a transgenic mouse containing the complete viral genome with mutant s gene.
Ge JH; Zhang LZ; Li JX; Liu H; Liu HM; He J; Yao YC; Yang YJ; Yu HY; Hu YP
World J Gastroenterol; 2004 Nov; 10(21):3141-5. PubMed ID: 15457560
[TBL] [Abstract][Full Text] [Related]
4. Analysis of liver disease, nuclear HBcAg, viral replication, and hepatitis B virus DNA in liver and serum of HBeAg Vs. anti-HBe positive carriers of hepatitis B virus.
Hadziyannis SJ; Lieberman HM; Karvountzis GG; Shafritz DA
Hepatology; 1983; 3(5):656-62. PubMed ID: 6618432
[TBL] [Abstract][Full Text] [Related]
5. Elimination of immunodominant epitopes from multispecific DNA-based vaccines allows induction of CD8 T cells that have a striking antiviral potential.
Riedl P; Wieland A; Lamberth K; Buus S; Lemonnier F; Reifenberg K; Reimann J; Schirmbeck R
J Immunol; 2009 Jul; 183(1):370-80. PubMed ID: 19542448
[TBL] [Abstract][Full Text] [Related]
6. [Study on the differences of two mouse models of hepatitis B virus infection by transduction with rAAV8-1. 3HBV].
Wang G; Dong XY; Tian WH; Yu CJ; Zheng G; Gao J; Wang GJ; Wei GC; Zhou YS; Wu XB
Bing Du Xue Bao; 2012 Sep; 28(5):541-7. PubMed ID: 23233931
[TBL] [Abstract][Full Text] [Related]
7. Relationship between hepatitis B virus deoxyribonucleic acid, HBeAg/anti-HBe status in serum and HBcAg in liver: its clinical significance in chronic HBsAg carriers.
Kiyosawa K; Nakamura M; Sodeyama T; Tanaka E; Nakano Y; Furuta S
Jpn J Med; 1988 Aug; 27(3):267-71. PubMed ID: 3057267
[TBL] [Abstract][Full Text] [Related]
8. Anti-hepatitis B virus activity of lithospermic acid, a polyphenol from Salvia miltiorrhiza, in vitro and in vivo by autophagy regulation.
Zhu S; Wen H; Wang W; Chen Y; Han F; Cai W
J Ethnopharmacol; 2023 Feb; 302(Pt A):115896. PubMed ID: 36334815
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of hepatitis B virus replication by APOBEC3G in vitro and in vivo.
Lei YC; Hao YH; Zhang ZM; Tian YJ; Wang BJ; Yang Y; Zhao XP; Lu MJ; Gong FL; Yang DL
World J Gastroenterol; 2006 Jul; 12(28):4492-7. PubMed ID: 16874860
[TBL] [Abstract][Full Text] [Related]
10. Relationship between HBcAg in serum and liver and HBV replication in patients with HBsAg-positive chronic liver disease.
Pontisso P; Chemello L; Fattovich G; Alberti A; Realdi G; Brechot C
J Med Virol; 1985 Oct; 17(2):145-52. PubMed ID: 4056756
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B virus core and e antigen: immune recognition and use as a vaccine carrier moiety.
Schödel F; Peterson D; Milich D
Intervirology; 1996; 39(1-2):104-10. PubMed ID: 8957676
[TBL] [Abstract][Full Text] [Related]
12. Biologic and prognostic significance of hepatocyte hepatitis B core antigen expressions in the natural course of chronic hepatitis B virus infection.
Hsu HC; Su IJ; Lai MY; Chen DS; Chang MH; Chuang SM; Sung JL
J Hepatol; 1987 Aug; 5(1):45-50. PubMed ID: 3655309
[TBL] [Abstract][Full Text] [Related]
13. Histopathological analysis of chronic hepatitis B virus (HBV) infection in relation to HBV replication.
Suzuki K; Uchida T; Shikata T
Liver; 1987 Oct; 7(5):260-70. PubMed ID: 3320656
[TBL] [Abstract][Full Text] [Related]
14. [An in vitro model of hepatitis B virus gene replication and expression in primary rat hepatocytes transfected with circular viral DNA].
Yao YQ; Zhang DF; Luo Y; Zhang DZ; Huang AL; Wang B; Zhou WP; Ren H; Guo SH
Zhonghua Gan Zang Bing Za Zhi; 2002 Aug; 10(4):275-8. PubMed ID: 12223138
[TBL] [Abstract][Full Text] [Related]
15. Membrane staining for hepatitis B surface antigen on hepatocytes: a sensitive and specific marker of active viral replication in hepatitis B.
Chu CM; Liaw YF
J Clin Pathol; 1995 May; 48(5):470-3. PubMed ID: 7629296
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B surface antigen: relation to hepatitis B replication parameters in HBeAg-negative chronic hepatitis B.
Manesis EK; Papatheodoridis GV; Tiniakos DG; Hadziyannis ES; Agelopoulou OP; Syminelaki T; Papaioannou C; Nastos T; Karayiannis P
J Hepatol; 2011 Jul; 55(1):61-8. PubMed ID: 21145875
[TBL] [Abstract][Full Text] [Related]
17. PreS antigen expression and anti-preS response in hepatitis B virus infections: relationship to serum HBV-DNA, intrahepatic HBcAg, liver damage and specific T-cell response.
Petit MA; Capel F; Zoulim F; Dubanchet S; Chemin I; Penna A; Ferrari C; Trépo C
Arch Virol Suppl; 1992; 4():105-12. PubMed ID: 1280500
[TBL] [Abstract][Full Text] [Related]
18. Strong and multi-antigen specific immunity by hepatitis B core antigen (HBcAg)-based vaccines in a murine model of chronic hepatitis B: HBcAg is a candidate for a therapeutic vaccine against hepatitis B virus.
Akbar SM; Chen S; Al-Mahtab M; Abe M; Hiasa Y; Onji M
Antiviral Res; 2012 Oct; 96(1):59-64. PubMed ID: 22884884
[TBL] [Abstract][Full Text] [Related]
19. Role of core protein mutations in the development of occult HBV infection.
Chen J; Liu B; Tang X; Zheng X; Lu J; Zhang L; Wang W; Candotti D; Fu Y; Allain JP; Li C; Li L; Li T
J Hepatol; 2021 Jun; 74(6):1303-1314. PubMed ID: 33453326
[TBL] [Abstract][Full Text] [Related]
20. Antiviral effect of hepatitis B virus S/C gene loci antisense locked nucleic acid on transgenic mice in vivo.
Deng YB; Qin HJ; Luo YH; Liang ZR; Zou JJ
Genet Mol Res; 2015 Aug; 14(3):10087-95. PubMed ID: 26345946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
